A Mixed Methods Evaluation of HPI Resilience Intervention Study
Public ClinicalTrials.gov record NCT03451240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the Resilience Study is to determine the impact of the Corporate Athlete® Resilience product through recalibrating mindset and changing resilience supportive behavior. Analysis will be performed via Survey and Study Interviews (two methods) to determine how the CAR Training recalibrated and impacted the Research Participants mindset and resilience state. 1\. Tool: Stress Mindset Measure-General (SMM-G) Additional analysis will evaluate participants' engagement in behavior changes in the first 30 days. 2\. Tool: Energy Management Behaviors. Secondary objectives include further analysis to determine if the intervention group demonstrated significant improvements in the following measures: 1\. Brief Resilience Scale (BRS) 2\. Public Health Surveillance Wellbeing (PHS-WB) 3\. Sleep Habits (Rand MOS) 4\. Health, Wellbeing and Productivity (SF36, HPQ) 5\. Work Productivity and Activity Impairment (WPAI) 6\. Brief Cope 7\. Perceived Stress (PSS) In addition, demographic assessments will be collected.
Study identification
- NCT ID
- NCT03451240
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 110 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2017
- Primary completion
- Dec 30, 2017
- Completion
- Dec 30, 2017
- Last update posted
- Feb 28, 2018
2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Human Performance Institute | Orlando | Florida | 32827 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03451240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2018 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03451240 live on ClinicalTrials.gov.